Adaptilens
PrivateLast Round
Series A
Apr 29, 2024
Total Funding Raised
$19.26M
Company Overview
Adaptilens operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in April 2024.
Adaptilens is a medical device company that develops an innovative intraocular lens that mimics the natural human lens, providing patients with clear vision at all distances and reducing their reliance on glasses and contact lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptilens Comparables
Compare Adaptilens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LensGen | 90% | |
| JelliSee Ophthalmics Inc. | 90% | |
| Atia Vision | 89% |
For institutional investors. Book with your work email.
Adaptilens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2024 | ||||
| Grant | May 5, 2022 | ||||
| Grant | Jun 14, 2021 | ||||
| Seed | Nov 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adaptilens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Life Sciences Center | Grant |
| Pillar VC | Series A, Seed |
| Accanto Partners | Seed, Series A |
| 380 Cap | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2020
$1.6M round led by Pillar VC
For institutional investors. Book with your work email.
Adaptilens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adaptilens's valuation, stock price, and market status.
Is Adaptilens a public or private company?
Adaptilens is a private company.
What is the current stock price of Adaptilens?
Adaptilens is a private company, so its shares have no public market price. Caplight tracks Adaptilens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adaptilens worth (valuation)?
Valuation information for Adaptilens is not publicly available.
Can I buy Adaptilens stock?
Adaptilens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adaptilens's last funding round?
Adaptilens's most recent funding round was Series A on April 29, 2024.
Who are the main investors in Adaptilens?
Key investors in Adaptilens include Pillar VC.
Will Adaptilens IPO soon?
No public IPO plans have been announced for Adaptilens.
How can I track Adaptilens secondary market activity?
Caplight tracks bids, offers, and trades in Adaptilens's shares on secondary markets.